Globus Medical (GMED) Competitors $84.72 -0.19 (-0.22%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GMED vs. EW, RMD, IDXX, DXCM, STE, PODD, HOLX, BAX, MASI, and TFXShould you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Masimo (MASI), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Globus Medical vs. Edwards Lifesciences ResMed IDEXX Laboratories DexCom STERIS Insulet Hologic Baxter International Masimo Teleflex Globus Medical (NYSE:GMED) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, community ranking, risk, earnings, profitability, analyst recommendations and valuation. Does the MarketBeat Community believe in GMED or EW? Edwards Lifesciences received 767 more outperform votes than Globus Medical when rated by MarketBeat users. Likewise, 71.05% of users gave Edwards Lifesciences an outperform vote while only 67.75% of users gave Globus Medical an outperform vote. CompanyUnderperformOutperformGlobus MedicalOutperform Votes56167.75% Underperform Votes26732.25% Edwards LifesciencesOutperform Votes132871.05% Underperform Votes54128.95% Do analysts recommend GMED or EW? Globus Medical currently has a consensus target price of $88.18, suggesting a potential upside of 4.09%. Edwards Lifesciences has a consensus target price of $75.67, suggesting a potential upside of 7.34%. Given Edwards Lifesciences' higher possible upside, analysts clearly believe Edwards Lifesciences is more favorable than Globus Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Globus Medical 1 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.58Edwards Lifesciences 0 Sell rating(s) 16 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.38 Which has preferable earnings & valuation, GMED or EW? Edwards Lifesciences has higher revenue and earnings than Globus Medical. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobus Medical$2.48B4.65$122.87M$0.67126.45Edwards Lifesciences$6.31B6.58$1.40B$6.9310.17 Do institutionals & insiders hold more shares of GMED or EW? 95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 18.5% of Globus Medical shares are owned by company insiders. Comparatively, 1.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, GMED or EW? Globus Medical has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Is GMED or EW more profitable? Edwards Lifesciences has a net margin of 70.82% compared to Globus Medical's net margin of 3.69%. Edwards Lifesciences' return on equity of 20.76% beat Globus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Globus Medical3.69% 9.98% 7.92% Edwards Lifesciences 70.82%20.76%15.27% Does the media prefer GMED or EW? In the previous week, Edwards Lifesciences had 62 more articles in the media than Globus Medical. MarketBeat recorded 74 mentions for Edwards Lifesciences and 12 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.09 beat Edwards Lifesciences' score of 0.31 indicating that Globus Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 25 Very Positive mention(s) 3 Positive mention(s) 35 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryEdwards Lifesciences beats Globus Medical on 12 of the 18 factors compared between the two stocks. Ad Darwin2025: Digital Asset Insights You Need to KnowCryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! Get Globus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GMED vs. The Competition Export to ExcelMetricGlobus MedicalSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.54B$4.53B$5.38B$20.17BDividend YieldN/A36.79%5.13%3.50%P/E Ratio126.4525.65102.4643.99Price / Sales4.6546.931,234.8517.76Price / Cash23.1053.6240.4721.29Price / Book2.835.947.094.71Net Income$122.87M$13.99M$119.65M$986.85M7 Day Performance4.46%3.27%2.06%3.76%1 Month Performance14.63%4.64%-2.46%4.65%1 Year Performance84.25%47.15%33.95%27.72% Globus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GMEDGlobus Medical4.504 of 5 stars$84.72-0.2%$88.18+4.1%+84.3%$11.54B$2.48B126.455,000Analyst DowngradePositive NewsEWEdwards Lifesciences4.1597 of 5 stars$70.17-0.3%$75.67+7.8%+5.1%$41.39B$6.31B10.1819,800Analyst RevisionRMDResMed4.8188 of 5 stars$243.14-0.2%$225.70-7.2%+59.7%$35.69B$4.69B32.269,980Positive NewsIDXXIDEXX Laboratories4.8723 of 5 stars$417.68-0.2%$552.38+32.2%-12.8%$34.20B$3.66B40.4411,000News CoveragePositive NewsDXCMDexCom4.9861 of 5 stars$72.87-2.1%$104.59+43.5%-34.3%$28.46B$3.62B44.609,600Insider TradeNews CoverageSTESTERIS4.9927 of 5 stars$214.97-0.4%$253.00+17.7%+5.8%$21.22B$5.14B49.2618,179Ex-DividendPositive NewsPODDInsulet4.4129 of 5 stars$260.70-0.5%$253.27-2.9%+41.1%$18.29B$1.70B45.033,000News CoveragePositive NewsHOLXHologic4.8988 of 5 stars$78.67-0.1%$89.91+14.3%+9.4%$18.27B$4.03B23.636,990Positive NewsBAXBaxter International4.4971 of 5 stars$33.42+1.3%$40.91+22.4%-7.4%$17.06B$14.81B165.6160,000MASIMasimo4.2479 of 5 stars$172.14+1.8%$163.67-4.9%+86.7%$9.22B$2.05B117.805,200Analyst ForecastTFXTeleflex4.8862 of 5 stars$191.23+0.3%$259.25+35.6%-12.1%$8.88B$2.97B37.8714,500Analyst Downgrade Related Companies and Tools Related Companies Edwards Lifesciences Alternatives ResMed Alternatives IDEXX Laboratories Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Hologic Alternatives Baxter International Alternatives Masimo Alternatives Teleflex Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:GMED) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
